Description

Prochlorperazine Edisylate is a high-purity pharmaceutical salt form of the potent phenothiazine derivative, prochlorperazine. This compound is critical for its reliable antiemetic and antipsychotic properties, serving as a key active pharmaceutical ingredient (API) in the formulation of injectable and other medicinal products. It is primarily required by pharmaceutical manufacturers and research institutions engaged in the development and production of treatments for severe nausea, vomiting, and certain psychiatric conditions. Our supply is characterized by stringent quality control to meet the exacting standards of the global pharmaceutical industry.

Application

• Pharmaceutical API: Primary use as the active ingredient in injectable antiemetic formulations.
• Antipsychotic Medication: Used in the manufacture of drugs for managing symptoms of schizophrenia and other psychotic disorders.
• Control of Severe Nausea & Vomiting: Essential for medications prescribed post-operatively or for patients undergoing chemotherapy or radiation therapy.
• Migraine Treatment Adjunct: Incorporated into therapeutic regimens for the management of acute migraine attacks.
• Veterinary Pharmaceutical Use: Applied in veterinary medicine for antiemetic purposes in animals.
• Reference Standard: Serves as a high-purity analytical standard in quality control laboratories for drug testing and verification.
• Research & Development: Utilized in pharmacological studies and the development of novel drug delivery systems.

Basic Information

Product Name	Prochlorperazine Edisylate
CAS No.	7081-50-7
Molecular Formula	C20H24ClN3S • C2H6O4S
Molecular Weight	564.09 g/mol
Synonyms	Prochlorperazine Ethanedisulfonate; Prochlorperazine Edisilate; 2-Chloro-10-[3-(4-methylpiperazin-1-yl)propyl]phenothiazine Edisylate; Compazine Edisylate; Stemetil; Novamin; Chlorperazine Edisylate; Prochlorperazine Dimaleate (related salt form)
EINECS	Contact for details

Quality Control

Our Prochlorperazine Edisylate is manufactured and tested to meet stringent pharmacopeial standards, including USP and EP monographs where applicable. Every batch undergoes comprehensive analytical testing for identity, potency, purity, and specified impurities. A Certificate of Analysis (COA) documenting results for assay, related substances, residual solvents, and other critical parameters is provided to ensure full traceability and compliance for pharmaceutical use.

Storage

Preserve in a tightly closed container, protected from light. Store in a cool, dry place at a controlled room temperature (15-25°C). This product is hygroscopic (moisture-sensitive) and must be kept in a dry environment to prevent degradation.

Specification

Item	Specification
Appearance	White or almost white crystalline powder
Identification (IR)	Conforms to standard
Identification (HPLC)	Retention time corresponds to reference standard
Assay (HPLC)	98.0% - 102.0% (on anhydrous basis)
Water Content (KF)	≤ 5.0%
Related Substances (HPLC)	Individual impurity: ≤ 0.5% Total impurities: ≤ 2.0%
Residual Solvents (GC)	Complies with ICH Q3C guidelines
Heavy Metals	≤ 20 ppm
Sulfated Ash	≤ 0.1%

Note: Specifications can be tailored. Please contact us for the detailed technical data sheet of a specific grade.